As a result of diverse pharmacokinetic profiles, oral formulations are not interchangeable with extended launch on an mg-mg foundation on account of diverse pharmacokinetic profilesCould possibly be provided as monotherapy or as adjunctive therapy with stimulants. The extended-launch is just not interchangeable Along with the fast-launch product or